Core Insights - In the third quarter of 2025, the company reported a revenue of 888,596,339.30 yuan, representing a year-on-year growth of 11.02% [1] - The net profit attributable to shareholders of the listed company was 204,153,069.25 yuan, showing a year-on-year increase of 12.68% [1]

证券代码：300910 证券简称：瑞丰新材 公告编号：2025-051 新乡市瑞丰新材料股份有限公司 关于公司对外投资并设立合资公司的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、交易概述 1、基本情况 为贯彻执行公司的战略规划和发展目标，优化业务布局，满足区域客户的配 套需求，增强公司在全球市场的综合竞争力，新乡市瑞丰新材料股份有限公司（简 称"公司"）全资子公司瑞丰润滑油添加剂（香港）有限公司（以下简称"瑞丰 香港"）拟与沙特阿拉伯公司 Farabi Downstream Company（简称"法拉比下游 公司"）在沙特阿拉伯延布市设立合资公司瑞丰法拉比润滑油添加剂公司（简称 "瑞丰法拉比"），建设辐射中东、非洲、印度等市场的生产基地，为区域客户 或其他西方地理或全球 TOP 客户提供有竞争力的润滑油添加剂产品。根据双方 初步达成的合作意向，合资公司中瑞丰香港将持股 60%，法拉比下游公司持股 40%。 2、投资概况 企业名称：Farabi Downstream Company 企业类型：有限责任公司 注册号：2055104473 注册地址：5 ...

Core Viewpoint - 瑞丰新材's subsidiary 瑞丰润滑油添加剂(香港)有限公司 plans to establish a joint venture with Farabi Downstream Company in Saudi Arabia to create a production base for lubricant additives targeting the Middle East, Africa, and India markets [1] Group 1: Joint Venture Details - The joint venture, named 瑞丰法拉比润滑油添加剂公司, will be located in Yanbu, Saudi Arabia [1] - 瑞丰香港 will hold a 60% stake in the joint venture, while Farabi Downstream Company will hold 40% [1] Group 2: Investment and Construction Plans - The total investment for the project is estimated to be approximately $246 million, with the first phase of construction expected to cost around $127 million [1] - The project will be developed in 2 to 3 phases, focusing on producing core single agents and mainstream compound varieties of lubricant additives [1]

Core Viewpoint - The company, Ruifeng New Materials (300910.SZ), announced plans to establish a joint venture, Ruifeng Farabi, with a Saudi Arabian company in Yanbu, Saudi Arabia, to create a production base targeting markets in the Middle East, Africa, and India [1] Investment Details - The total investment for the joint venture is approximately $246 million, with the first phase of construction estimated at $127 million [1] Market Strategy - The production base aims to provide competitive lubricant additive products to regional customers and other top global clients from Western geographies [1]

证券代码：300910 证券简称：瑞丰新材 公告编号：2025-050 新乡市瑞丰新材料股份有限公司 关于2025年三季度证券投资与衍生品交易情况的专项说明 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 根据《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规 范运作》《深圳证券交易所创业板上市公司自律监管指南第1号——业务办理》 等有关规定的要求，公司董事会对公司2025年三季度证券投资与衍生品交易情况 进行了核查，现将相关情况说明如下： 一、证券投资与衍生品交易审议批准情况 公司于2025年7月30日召开的第四届董事会第九次会议、于2025年8月15日召 开的2025年第一次临时股东大会审议通过了《关于开展证券投资及衍生品交易的 议案》，同意公司及子公司在充分保障日常经营性资金需求并有效控制风险的前 提下，使用自有资金不超过人民币5亿元（或等值外币）进行证券投资及衍生品 交易，在该额度内可由公司及子公司在各投资产品间自由分配，共同循环使用， 投资取得的收益可以进行再投资，再投资的金额包含在本次预计投资额度范围内。 公司开展证券投资的业务范围为境 ...

证券代码：300910 证券简称：瑞丰新材 公告编号：2025-048 新乡市瑞丰新材料股份有限公司 第四届董事会第十一次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 新乡市瑞丰新材料股份有限公司（以下简称"公司"）第四届董事会第十一次 会议通知于2025年10月20日以电子邮件等方式向各位董事发出，会议于2025年10 月27日以现场会议结合通讯形式在公司会议室召开。本次会议由公司董事长郭春 萱先生召集并主持，应出席会议的董事9人，实际出席会议的董事9人，公司高级 管理人员列席了会议。 具体内容详见公司刊载于中国证监会指定创业板信息披露网站巨潮资讯网 （http://www.cninfo.com.cn）上的相关公告。 表决结果：9票赞成，0票反对，0票弃权。 公司董事会审计委员会已审议通过了该议案。 本次会议的召集、召开及表决符合《中华人民共和国公司法》及《新乡市瑞丰新 材料股份有限公司章程》（以下简称《公司章程》）的有关规定，会议合法有效。 二、董事会会议审议情况 1、审议通过《关于公司<2025年第三季度报告>的议 ...

Core Insights - The company reported a revenue of 25.508 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 10.87% [1] - The net profit attributable to shareholders reached 574 million yuan, showing a year-on-year increase of 14.85% [1] - Basic earnings per share were 1.96 yuan, reflecting a year-on-year growth of 12.00% [1]

Financial Performance - The company's revenue for Q3 2025 reached ¥888,596,339.30, an increase of 11.02% compared to the same period last year[5] - Net profit attributable to shareholders was ¥204,153,069.25, reflecting a growth of 12.68% year-on-year[5] - The basic earnings per share (EPS) for the period was ¥0.70, up by 12.90% from the previous year[5] - The total operating revenue for the current period reached ¥2,550,763,303.96, an increase of 10.85% compared to ¥2,300,648,255.40 in the previous period[23] - The net profit for the current period is CNY 575,932,236.97, an increase from CNY 502,299,789.74 in the previous period, representing a growth of approximately 14.6%[24] - Operating profit for the current period is CNY 670,269,210.70, compared to CNY 585,245,739.53 in the previous period, indicating an increase of about 14.5%[24] - Total revenue from operating activities reached CNY 2,861,397,828.56, up from CNY 2,352,581,844.85, reflecting a growth of approximately 21.5%[26] - The company reported a total comprehensive income of CNY 574,395,277.57, compared to CNY 501,275,275.78 in the previous period, which is an increase of approximately 14.6%[25] - Basic earnings per share for the current period is CNY 1.96, up from CNY 1.75 in the previous period, representing a growth of about 12.0%[25] Cash Flow and Investments - The net cash flow from operating activities for the year-to-date was ¥547,906,364.97, showing a significant increase of 112.69%[5] - The net cash flow from operating activities increased by 112.69% to ¥547,906,364.97 compared to ¥257,602,730.07 in the same period last year, primarily due to increased sales collections[12] - The company’s investment activities generated a net cash flow of -¥317,144,114.21, a 31.49% improvement from -¥462,935,419.41 in the previous year[12] - The company’s financing activities resulted in a net cash flow of -¥86,667,596.77, a 72.51% improvement from -¥315,222,857.49 in the same period last year[12] - The company’s investment activities resulted in a net cash outflow of CNY 317,144,114.21, an improvement from a net outflow of CNY 462,935,419.41 in the previous period[27] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥4,785,863,744.23, representing an increase of 11.25% from the end of the previous year[5] - Total liabilities increased to ¥1,100,858,765.93 from ¥935,777,537.76, reflecting a growth of 17.64%[22] - The equity attributable to shareholders of the parent company rose to ¥3,663,349,967.52 from ¥3,344,602,539.15, an increase of 9.53%[22] - The company’s equity attributable to shareholders increased to ¥3,663,349,967.52, a rise of 9.53% compared to the previous year-end[5] - The cash and cash equivalents at the end of the period were ¥625,064,877.18, compared to ¥479,222,952.22 at the beginning of the period, indicating a growth of 30.49%[20] Operational Efficiency - The company reported a decrease in receivables, with notes receivable down by 96.19% due to reduced commercial acceptance bills received from customers[9] - Accounts receivable decreased to ¥417,537,042.86 from ¥487,497,341.15, showing a decline of 14.34%[20] - Inventory increased to ¥641,001,377.76 from ¥550,263,024.40, representing a rise of 16.52%[21] - The company experienced a 30.43% increase in cash and cash equivalents, totaling ¥625,064,877.18, driven by net cash inflows from operating activities[9] - The company experienced a 47.09% reduction in non-operating expenses, totaling ¥3,302,916.26, mainly due to decreased donation expenses and tax penalties[11] Financial Expenses and Income - Investment income rose significantly by 307.30% to ¥6,464,306.40, attributed to the difference in value recognition of financial products compared to the previous period[11] - The company reported a decrease in financial expenses by 118.04%, amounting to ¥1,824,692.67, due to reduced interest income and increased interest expenses[11] - The company’s financial expenses included interest expenses of CNY 8,352,386.76, which increased from CNY 5,326,318.15 in the previous period, reflecting a rise of approximately 57.0%[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,668, with the largest shareholder holding 36.55% of the shares[14] - The company’s largest shareholder, Guo Chunxuan, holds 108,172,953 shares, representing 36.55% of total shares[14] Future Outlook - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[19] Audit Information - The company did not undergo an audit for the Q3 financial report[4]

Summary of Key Points from Conference Call Records Industry Overview - **Traditional Industries in China**: The cyclical nature of traditional industries is weakening, with a shift in fixed asset investment towards asset management. This change is driven by a decline in risk-free returns, which is fostering the development of capital markets [1][5][6]. - **Economic Policy Shift**: The 20th Central Committee emphasized economic construction, marking a transition to a more proactive development strategy, which is beneficial for technology and consumer sectors [1][7]. - **Market Outlook**: The Chinese market is expected to stabilize above 4,000 points by 2025, with no second bottom anticipated. Adjustments in the market are seen as buying opportunities [1][3][10]. Key Sectors and Companies - **Metals Sector**: Industrial metals are expected to benefit from improved risk appetite due to US-China trade negotiations. The Federal Reserve's potential interest rate cuts may lead to increased liquidity, positively impacting both precious and industrial metal prices [1][12]. - **Chemical Industry**: Supply-side pressures are expected to ease, with leading companies in coal chemicals (e.g., Hualu Hengsheng), spandex (e.g., Huafeng Chemical), and refrigerants showing growth potential [1][16][19]. - **Logistics Sector**: The express delivery industry is experiencing a price increase trend, with major companies like Shentong and YTO showing strong growth. The focus is on companies with robust performance and reasonable valuations [4][21][22]. - **Coal Market**: The coal market is recovering due to extreme weather and early heating season demands, with prices expected to exceed 800 RMB/ton by 2026 [4][27][28]. - **Steel Industry**: The steel sector is in a bottom reversal phase, with demand and supply factors supporting price stability. Leading companies like Baosteel and Hualing are recommended for investment [4][29][30]. Investment Opportunities - **Emerging Technologies**: New technologies are highlighted as a primary investment focus, with cyclical finance seen as a dark horse. The investment landscape is expected to diversify but remain structured [1][11][10]. - **New Materials**: Investment opportunities in new materials include lubricating oil additives and high-frequency resins, with companies like Ruifeng New Materials and Lianlong showing promise [1][20]. - **Public Utilities**: The public utility sector is projected to experience significant valuation recovery, particularly in power generation, with expectations of doubling PE ratios [40][41]. Additional Insights - **US-China Trade Relations**: China's systematic and mature response to trade challenges has increased market confidence and risk appetite, suggesting that recent price declines present buying opportunities rather than sell signals [8][9]. - **Real Estate Sector**: The relationship between high-quality real estate development and economic contribution is emphasized, with a need for stable investment and reasonable price expectations to achieve high-quality growth [35]. - **Future Trends**: The focus on innovation, green low-carbon initiatives, and structural upgrades in the petrochemical industry is expected to drive growth in the coming years [26]. This summary encapsulates the critical insights and projections from the conference call, providing a comprehensive overview of the current state and future outlook of various industries in China.

Investment Rating - The investment rating for the company is maintained at "Buy" [1][4]. Core Insights - The company reported a Q3 revenue of 1.514 billion RMB, representing a year-over-year increase of 4.77% and a quarter-over-quarter increase of 0.01%. The net profit attributable to the parent company was 151 million RMB, showing a year-over-year growth of 60.83% and a quarter-over-quarter growth of 13.17% [1]. - The company has seen a steady performance in its anti-aging agent business and continuous market expansion in its lubricant additive business. The gross margin for Q3 was 21.97%, up 1.37 percentage points year-over-year [2]. - The life sciences division has made significant progress, with key projects achieving stable production and sales, and new products entering the trial production phase [3]. - The profit forecast for the company has been revised upwards, with expected net profits of 539 million RMB, 601 million RMB, and 669 million RMB for 2025, 2026, and 2027 respectively, reflecting year-over-year growth rates of 26%, 12%, and 11% [4]. Summary by Sections Financial Performance - Q3 revenue was 1.514 billion RMB, with a year-over-year increase of 4.77% and a quarter-over-quarter increase of 0.01%. For the first three quarters of 2025, revenue reached 4.509 billion RMB, up 5.72% year-over-year [1]. - The gross margin for Q3 was 21.97%, with a year-over-year increase of 1.37 percentage points [2]. Business Development - The anti-aging agent business has maintained steady performance, while the lubricant additive business is experiencing ongoing market expansion and capacity ramp-up [2]. - The life sciences division has established a core focus on bio-blocks and synthetic biology, with significant sales achievements and product trials underway [3]. Profit Forecast and Valuation - The net profit forecast for 2025-2027 has been adjusted upwards to 539 million RMB, 601 million RMB, and 669 million RMB, with corresponding EPS of 2.35, 2.62, and 2.91 RMB [4]. - The target price for the company is set at 44.54 RMB, based on a 17x PE ratio for 2026 [4].